Pharmafile Logo

Conference Live: Case study

February 4, 2019 | Case study, Conference Live 

How we helped track and evaluate conference performance over time across multiple international events

Our client planned to have a significant presence at key global conferences over the course of a year. Find out how we effectively monitored perceptions of their brand across different regions over time.

The challenge:
Our client was developing a portfolio for the treatment of a chronic neurodegenerative disease and planned to have a significant presence at key neuroscience conferences over the coming year. With conferences being a considerable investment, they wanted to understand:

  • How various aspects of their presence and presentations n(vs competitors) at each event impacted their target.

  • The impact conference presence would have on delegates’ perceptions of them as an upcoming player in the field of neuroscience and how these perceptions would change after each event.

The solution:
Using our proprietary tool Conference Live, we conducted research at multiple conferences across EU and US for a year. For each event, we recruited a sample of Neurologists, Psychiatrists, and Physicians. As the aim of the research was to measure perceptions over time, we recruited new respondents for each conference to capture ‘current’ perceptions and not those with views potentially affected by participation in earlier surveys.

Before, during and after each event we used online and mobile surveys to capture perceptions around the therapy area, companies engaging in this space, and of our client as an upcoming player. This allowed for a comparative analysis and a depiction of any changes over time.

To gain insight into the key aspects of physicians’ experiences, we administered a series of in-the-moment mini-questionnaires evaluating visits to a range of exhibition stands and the main scientific presentations of the day as well as a number of smaller poster presentations.

The outputs:
By conducting research over the course of several events, our client was able to effectively monitor the awareness and knowledge of their upcoming portfolio over time and learn how this differed in each region. Furthermore, they were able to track any changes in physicians’ perceptions of them becoming a key player, with clear signals as to which had been the most pivotal presentations and papers that shaped opinion.

Real-time insights meant almost immediate feedback on the initiatives they ran at each conference including the effectiveness of papers, posters, exhibition space, and marketing messages. In addition to identifying the most successful initiatives, we were also able to provide further insight into ways in which they could improve any that were less successful at future events.

Find out more about Conference Live »

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Research Partnership has been ranked in the Pharma Times Pharma Fast 50

Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research...

Women’s health in emerging markets

Why can understanding and improving women’s health in emerging markets be challenging? What strategies can global pharma develop to support women and overcome these challenges? Associate Director Rachel Howard and...

Research Partnership has published a new Living with Lupus (SLE) market report for 2017

SLE is a progressive and debilitating disease which affects 5 million people worldwide.

PEGASUS AND UCL JOIN FORCES IN INSPIRING HEALTHY DECISIONS

Pegasus, an Ashfield company, part of UDG Healthcare plc, is proud to announce the launch of its new propriety model for planning in health – CHANGE – which was developed...

Cool heads in a crisis?

Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics

Biosimilars: Bringing patients into the conversation

Published in eyeforpharma January 2017 by Mariel Metcalfe

Access and elimination: the future of DAAs in hepatitis C

Published in Pharmaphorum January 2017

EphMRA One Day Meeting

We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London

Video: Segmentation research

Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger...

Pharmaceutical Market Research Conference 2017

We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.